Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Benuvia Therapeutics
Benuvia Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Syndros
Dronabinol
2017-03-23
2028
Vomiting
,
Nausea
,
Anorexia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Aspartame
medical sociology
,
renal insufficiency
,
thrombosis
,
venous thrombosis
,
neoplasms
,
obstructive sleep apnea
,
sleep apnea syndromes
,
apnea
,
chronic renal insufficiency
,
kidney diseases
,
carcinoma
,
salivary gland neoplasms
,
heart failure
,
non-hodgkin lymphoma
,
lymphoma
,
infections
,
human experimentation
,
hypersensitivity
,
venous thromboembolism
,
thromboembolism
,
b-cell lymphoma
,
contraception
,
hypertension
,
pulmonary hypertension
,
pulmonary arterial hypertension
,
stroke
,
respiratory insufficiency
,
communicable diseases
,
rheumatic diseases
,
collagen diseases
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
macular edema
,
retinal vein occlusion
,
wounds and injuries
,
wound healing
,
edema
,
postmenopause
,
endometriosis
,
chronic pain
,
interstitial cystitis
,
pelvic pain
,
syndrome
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use